Reproductive Health
2
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Oregon TherapeuticsWomen's Reproductive Health
Angeles TherapeuticsMyFamilyPlan
LabcorpInteractive Treatment
GSKreversible contraceptive methods
Clinical Trials (4)
Total enrollment: 2,121 patients across 4 trials
Mid-life Women: Preventing Unintended Pregnancy and STIs
Start: May 2008Est. completion: Sep 2009333 patients
Phase 2Completed
Web-based Preconception Health Education Tool
Start: Sep 2015Est. completion: Jun 2016292 patients
N/ACompleted
Study on Mhealth and Reproductive Health in Teens
Start: Jan 2014Est. completion: Jul 20151,419 patients
N/ACompleted
RH and Adolescents
Start: Mar 2013Est. completion: Nov 201577 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
6 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.